• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel
A trusted companion
GoldSeal™ Refurbished Invenia ABUS Ultrasound Systems

With the GE HealthCare GoldSeal refurbishment program for Ultrasound, you can feel confident you are purchasing a quality system at a great value that only the original equipment manufacturer (OEM) can deliver.

Invenia ABUS 2.0

Invenia ABUS 2.0, is the first FDA-approved ultrasound supplemental screening technology specifically designed for detecting cancer in dense breast tissue.

Designed for screening

Improve breast cancer detection by 35.7 percent over mammography alone¹

Remarkable image quality

Look differently at dense breast tissue with advanced interpretation tools

AI assistant

Helps to detect and characterize breast lesions for clinical confidence

Download sell sheet Request a quote

The GoldSeal advantage

With easily accessible technology, GoldSeal refurbished systems deliver on OEM quality

Selective process

Only systems with well-known and acceptable service histories qualify for GoldSeal

OEM quality

OEM factory-trained technicians refurbish equipment to meet ISO 13485-certified OEM specifications

Latest software

Includes installation of the latest possible software release and original OEM parts

Competitive warranty

Includes a parts and labor warranty. Extended warranties and service contracts are available

feature-full-looking-to-sell-desktop-ba-en
Looking to sell?

We buy used GE HealthCare equipment

When you sell us your used medical equipment, you’ll enjoy the benefit of working with experts. Not only can we help offset expenses related to deinstallation and disposal, but you can rely on us to offer a firm and fair value.

Disclaimer
GoldSeal systems are available based on current inventory on hand. Please complete the online quote request for up-to-date system availability.
References
  1. Tagliafico, Massimo Calabrese et al, Journal of Clinical Oncology 2016 34:16, 1882-1888.

Have a question? We’d love to hear from you.

Contact us

We're ready to support you in your moments that matter.

We’re sorry, a problem occurred with the form. Please try again.
Thank you for your inquiry.

We will be in touch soon.

Something went wrong

We will check and get back.